Characterization of SiO2 protective coatings on polycarbonate

SiO₂ protective coatings have been deposited on polycarbonate substrates by plasma ion assisted deposition. The influence of ion energy on the water permeability and the surface topography of the coatings was studied by infrared spectroscopy and atomic force microscopy. Coatings deposited at sufficiently high ion energies show a barrier effect against moisture uptake and considerably reduced film roughness. Both effects are attributed to an increase of the packing densities of the coatings.     

Synthesis of zirconium titanate with an ordered M-fergusonite (beta) structure

We report a new zirconium titanate compound (Zr,Ti)O₂ with 27.5-35 mol% titania (TiO₂) formed from the oxides at 35-38 kbar, 1400-1500 °C. Crystal structure investigations at atmospheric conditions with powder X-ray diffraction (XRD) and transmission electron microscopy (TEM) revealed a monoclinic structure related to that of M-fergusonite (beta). Unit-cell dimensions (from 27.5 to 35 mol% TiO₂): a=7.267(20)-7.340(2) Å, b=10.435(3)-10.429(1) Å, c=5.023(11)-5.040(1) Å, β=136.45(12)-137.55(1)°, V=262.44(92)-260.40(12) Å³, Z=4. Rietveld refinement (R_F=1.55) of a sample with 32.8 mol% TiO₂ indicates that site A is 8-fold coordinated, mostly occupied by Zr, while site B has 6-fold average coordination, occupied by Ti and Zr. Site B is at least partly ordered, as indicated by superstructure reflections 0 0 1 and −2 0 1 detected with TEM, reducing the space group from C2/c to C2. Pronounced streaking of selected diffraction spots is linked to the boundaries of lamellar domains in twin orientation, with twin planes either (200) or (20−2). Adjacent lamellae differ slightly in composition, causing subtle asymmetry of the twin diffraction patterns.     

Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry

A new method for the quantification of celecoxib in human plasma based on reversed-phase high-performance liquid chromatography (HPLC) coupled to atmospheric pressure chemical ionization (APCI) mass spectrometry (MS) after liquid-liquid extraction is presented. The method is rapid, sensitive and highly selective. The retention time of celecoxib was 2.3 min. The limit of quantification was 5 microg/L. Rofecoxib was used as internal standard. After validation, the method was used to study the pharmacokinetic profile of celecoxib following administration of a single oral dose (200 mg) in 12 healthy volunteers. Since celecoxib should be metabolized primarily by cytochrome 2C9 (CYP2C9), a poor metabolizer (PM) for this cytochrome P450 enzyme was included in the study. Pharmacokinetic characteristics (mean +/- SD) of extensive metabolizers (EM) were t(max) 2.9+/-1.2h, c(max) 842+/-280 microg/L, AUC(infinity) 6246+/-2147 microg h/L and t(1/2) 7.8+/-2.7h. The area under the curve (AUC(infinity)) for the PM was 12561 microg h/L. However, we found no noticeable increase in half life in the PM (11.5 h) after a single dose of celecoxib.     

Synthetic alpha-mannosyl ceramide as a potent stimulant for an NKT cell repertoire bearing the invariant Valpha19-Jalpha26 TCR alpha chain

A NKT cell repertoire is characterized by the expression of the Valpha19-Jalpha26 invariant TCR alpha chain (Valpha19 NKT cell). This repertoire, as well as a well-established Valpha14-Jalpha281 invariant TCR alpha(+) NKT cell subset (Valpha14 NKT cell), has been suggested to have important roles in the regulation of the immune system and, thus, is a major therapeutic target. Here, we attempted to find specific antigens for Valpha19 NKT cells. Valpha19 as well as Valpha14 NKT cells exhibited reactivity to alpha-galactosyl ceramide (alpha-GalCer). Thus, a series of monoglycosyl ceramides with an axially oriented glycosidic linkage between the sugar and ceramide moiety were synthesized and their antigenicity to Valpha19 NKT cells was determined by measuring their immune responses in culture with glycolipids. Comprehensive examinations revealed substantial antigenic activity for Valpha19 NKT cells by alpha-mannosyl ceramide.     

Electrochemical formation and clevage of bis-imidazolyls

Bis-(2,4,5-triphenylimidazolyls) result from the dimerization of 2,4,5-triphenylimidazolyls and from the nucleophilic attack of 2,4,5-triphenylimidazole anions upon 2,4,5-triphenylimidazolylium cations. The isomeric bis-imidazolyls consist of imidazole and isoimidazole systems. Imidazoles undergo only anodic oxidation, isoimidazoles only cathodic reduction. Therefore the bis-imidazolyls may be analyzed from their electrochemical behaviour. Bis-(2,4,5-triphenylimidazolyl)-1,2′ and bis-(2,4,5-triphenylimidazolyl)-1,4′ undergo reductive bond cleavage in an ē.c?.ē. mechanism from which 2,4,5-triphenyl-imidazole anions result. The electrochemical properties of one of the bis-imidazolyls agree with that of 1,4,5-triphenyl-2-(2,4,5-triphenylisoimidazolyl-4)-imidazole and not with that of bis-(2,4,5-triphenylimidazolyl)-2,4′ as reported in literature.     

Steam Reforming Reactions of Methanol Over Nickel and Copper Catalysts

Steam-reforming reactions of methanol over NiO/Al₂O₃ and CuO/ZnO have been investigated. Over the nickel catalyst, the reaction rate is of zero kinetic order with respect to either methanol or steam, and the activation energy is 12.4 kJmol^?1, whereas with copper catalyst, the rate is expressed according to the literature as kP_a/(1 + K_aP_a + K_b+P_b) in which “a” and “b” are methanol and steam, respectively. The rate-controlling step of the reaction is assigned to the dissociation of O-H bond with dehydrogenation of C-H bond proceed rapidly to form carbon oxides. With copper catalyst the intrinsic participation of a water molecule during the dehydrogenation of C-H bond leads to the formation of carbon dioxide. With nickel catalyst, the dehydrogenation proceed more rapidly than the migration of a water molecule from an alumina site to a nickel site and causes almost exclusively the formation of carbon monoxide and hydrogen at a lower reaction temperature.     

A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma

A practicable and selective liquid chromatography-mass spectrometry assay for the determination of two cyclooxygenase-2 inhibitors, etoricoxib and valdecoxib, in human plasma is presented. The analytical technique is based on reversed-phase high-performance liquid chromatography (HPLC) coupled to atmospheric pressure chemical ionisation (APCI) mass spectrometry (Finnigan Mat LCQ ion trap). Mass analysis was performed in the positive ion mode. The ion trap was operated in the tandem MS mode (MS2) and the transitions of etoricoxib (m/z 359.2 --> 280.3) and valdecoxib (m/z 315.1 --> 235.1) were followed by selected reaction monitoring. Retention times of etoricoxib and valdecoxib were 1.05 and 1.08 min, respectively. The method was validated over a linear range 10-2500 and 5-1000 microg/L using the other substrate as internal standard. After validation, the method was used to study the pharmacokinetic pro fi le of etoricoxib or valdecoxib in a healthy volunteer after administration of a single oral dose (valdecoxib, 20 mg; etoricoxib, 90 mg). The presented method was suf fi cient to cover more than 90% of the area under the plasma concentration time curve.